PatientsVille.com Logo

PatientsVille

Movicol Side Effects

Common Movicol Side Effects


The most commonly reported Movicol side effects (click to view or check a box to report):

Agitation (2)
Epilepsy (2)
Dizziness (2)
Blood Pressure Decreased (2)
Angioedema (2)
Fatigue (2)
Dyspnoea (2)
Syncope (2)
Febrile Neutropenia (2)
Lower Respiratory Tract Infection (2)
Nausea (2)
Injection Site Haemorrhage (2)
Inappropriate Antidiuretic Hormone Secretion (2)
Neoplasm Progression (1)
Influenza Virus Test Positive (1)
Neoplasm Malignant (1)
Insomnia (1)
International Normalised Ratio Increased (1)
Movement Disorder (1)
Muscular Weakness (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Movicol Side Effects Reported to FDA

The following Movicol reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Movicol on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Dyspnoea
This is a report of a 72-year-old male patient (weight: NA) from GB, suffering from the following symptoms/conditions: NA, who was treated with Movicol (dosage: 1 Sachet, start time: May 17, 2013), combined with:
  • Docusate
  • Aranesp
  • Dianeal Pd4 Glucose 1.36% W/v / 13.6 Mg/ml
  • Dianeal Pd4 Glucose 1.36% W/v / 13.6 Mg/ml
  • Extraneal (icodextrin 7.5%) Solution For Peritoneal Dialysis
  • Extraneal (icodextrin 7.5%) Solution For Peritoneal Dialysis
  • Castopril (12-5 Mg)
  • Nifedipine La
and developed a serious reaction and side effect(s). The consumer presented with:
  • Dyspnoea
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Movicol treatment in male patients, resulting in death side effect.

Hypertriglyceridaemia
This report suggests a potential Movicol Hypertriglyceridaemia side effect(s) that can have serious consequences. A 55-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Movicol (dosage: NA) starting Jun 29, 2013. Soon after starting Movicol the patient began experiencing various side effects, including:
  • Hypertriglyceridaemia
Drugs used concurrently:
  • Furosemide
  • Furosemide
  • Furosemide
  • Paracetamol
  • Paracetamol
  • Gaviscon
  • Granocyte
  • Valaciclovir
Although Movicol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypertriglyceridaemia, may still occur.

Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia
This Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia problem was reported by a physician from CH. A 73-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: laxative supportive care,gastritis prophylaxis. On Apr 03, 2012 this consumer started treatment with Movicol (dosage: 1 Dosage Forms Daily;). The following drugs were being taken at the same time:
  • Pantoprazole (40 Milligram Daily;)
  • Nifedipine (30 Milligram Daily;)
  • Cipralex (10 Milligram Daily;)
  • Cipralex (20 Milligram Daily;)
  • Approvel (150 Milligram Daily;)
When commencing Movicol, the patient experienced the following unwanted symptoms/side effects:
  • Inappropriate Antidiuretic Hormone Secretion
  • Hyponatraemia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as inappropriate antidiuretic hormone secretion, may become evident only after a product is in use by the general population.

Febrile Neutropenia, Cough
This is a report of a 44-year-old male patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: constipation,diffuse large b-cell lymphoma and was treated with Movicolon (dosage: Unk Mg, Unk) starting Dec 20, 2011. Concurrently used drugs:
  • Prednisone Tab (100 Mg, Unk)
  • Rituximab (800 Mg, Unk)
  • Cyclophosphamide (1660 Mg, Unk)
  • Vincristine (2 Mg, Unk)
  • Cotrim (480 Mg, Unk)
  • Valganciclovir (1000 Mg, Unk)
  • Pegfilgrastim (6 Mg, Unk)
  • Doxorubicin Hcl (110 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Febrile Neutropenia
  • Cough
The patient was hospitalized. This opens a possibility that Movicolon treatment could cause the above reactions, including febrile neutropenia, and some male subjects may be more susceptible.


Hepatic Neoplasm Malignant, Blood Test Abnormal, Renal Failure, Blood Urea Increased, Gastric Mucosa Erythema, Portal Hypertensive Gastropathy, Renal Failure Acute
A 80-year-old male patient (weight: NA) from GERMANY with the following symptoms/conditions: NA started Movicol treatment (dosage: Unk) on Oct 28, 2011. Soon after starting Movicol treatment, the subject experienced various side effects, including:
  • Hepatic Neoplasm Malignant
  • Blood Test Abnormal
  • Renal Failure
  • Blood Urea Increased
  • Gastric Mucosa Erythema
  • Portal Hypertensive Gastropathy
  • Renal Failure Acute
Concurrently used drugs:
  • Pramipexole Dihydrochloride (Unk)
  • Mirtazapine
  • Voltaren /sch/ (Unk)
  • Bydureon (2 Mg, Weekly (1/w))
  • Advantan (Unk)
  • Tramadol Hcl (Unk, Prn)
  • Ramipril
  • Naproxen (Unk)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Movicol.

Neoplasm Malignant, Neoplasm Progression
A female patient from NETHERLANDS (weight: NA) experienced symptoms, such as: NA and was treated with Movicolon(dosage: NA). The treatment was initiated on Jan 02, 2012. After that a consumer reported the following side effect(s):
  • Neoplasm Malignant
  • Neoplasm Progression
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Movicolon efficacy:
  • Tamoxifen Citrate (40 Mg, Unk)
  • Zometa (4 Mg,/100ml/28 Days)
  • Acetaminophen
  • Zometa (4 Mg,/100 Ml/ 28 Days)
  • Zometa (4 Mg, Once Every 4 Weeks)
  • Zometa (4 Mg/100/28 Days)


Wheezing, Diarrhoea
In this report, Movicol (nulytely /01053601/) was administered for the following condition: NA.A 89-year-old female consumer from (weight: NA) started Movicol (nulytely /01053601/) treatment (dosage: NA) on Nov 24, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Wheezing
  • Diarrhoea
A possible interaction with other drugs could have contributed to this reaction:
  • Oilatum (paraffin, Liquid)
  • Prednisolone
  • Furosemide
  • Vertab Sr (verapamil Hydrochloride)
  • Omeprazole
  • Oral Rehydration Salts (oral Rehydration Salt)
  • Levothyroxine (lexothyroxine)
  • Salamol (salbutamol)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Movicol (nulytely /01053601/) treatment could be related to the listed above side effect(s).

Dyspnoea
This is a report of the following Movicol /01053601/ side effect(s):
  • Dyspnoea
A 80-year-old male patient from UNITED KINGDOM (weight: NA) presented with the following condition: NA and received a treatment with Movicol /01053601/ (dosage: NA) starting: Sep 30, 2011.The following concurrently used drugs could have generated interactions:
  • Albuterol Sulfate Autohaler
  • Dexamethasone (2 Mg;bid;po ; 4 Mg;qd;po)
  • Dexamethasone (2 Mg;bid;po ; 4 Mg;qd;po)
  • Dexamethasone (2 Mg;bid;po ; 4 Mg;qd;po)
  • Dexamethasone (2 Mg;bid;po ; 4 Mg;qd;po)
  • Salmeterol
  • Ms Contin
  • Decapeptyl Sr
This report suggests that a Movicol /01053601/ treatment could be associated with the listed above side effect(s).

Abdominal Pain, Nausea, Vomiting
This Movicol (sodium Bicarbonate, Potassium Chloride, Macrogol) report was submitted by a 72-year-old male consumer from DENMARK (weight: NA). The patient was diagnosed with: NA and Movicol (sodium Bicarbonate, Potassium Chloride, Macrogol) was administered (dosage: NA) starting: Nov 22, 2010. The consumer developed a set of symptoms:
  • Abdominal Pain
  • Nausea
  • Vomiting
Other drugs used simultaneously:
  • Pantoloc (pantoprazole Sodium Sesquihydrate)
  • Oxazepam
  • Unikalk Forte (calcium)
  • Spiriva
  • Forteo
  • Innohep ((10000 Iu,1 In 1 D),subcutaneous)
  • Pinex (paracetamol)
  • Duragesic-100
The patient was hospitalized.Those unexpected symptoms could be linked to a Movicol (sodium Bicarbonate, Potassium Chloride, Macrogol) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Grand Mal Convulsion
This is a report of a possible correlation between Movicolon use and the following symptoms/side effect(s):
  • Grand Mal Convulsion
which could contribute to an assessment of Movicolon risk profile.A 66-year-old male consumer from IRELAND (weight: NA) was suffering from NA and was treated with Movicolon (dosage: NA) starting NS.Other concurrent medications:
  • Lamictal
  • Phenytoin (350 Mg;qd ; 200 Mg;bid)
  • Omeprazole
  • Septra
  • Keppra
  • Temodal (150 Mg;qd ; 360 Mg;qm;po)
  • Temodal (150 Mg;qd ; 360 Mg;qm;po)
  • Lactulose


Delirium
A female patient from NETHERLANDS (weight: NA) presented with the following symptoms: NA and after a treatment with Movicolon Poeder Voor Drank In Sachet (dosage: 1 Dosage Forms;) experienced the following side effect(s):
  • Delirium
The treatment was started on Dec 29, 2009. Movicolon Poeder Voor Drank In Sachet was used in combination with the following drugs:
  • Fucidin Tablet Omhuld 250mg (1500 Milligram;)
  • Metoprolol (100 Milligram;)
  • Fragmin 2500 Injvlst 12.500ie/ml Wwsp 0.2ml (1 Dosage Forms;)
  • Amlodipine Merck Tablet 5mg (10 Milligram;)
  • Dexamethasone Pch Tablet 4mg (8 Milligram;)
  • Zyvox
  • Aprovel Tablet Filmomhuld 150mg (300 Milligram;)
  • Cremor Triamcinoloni Acetonidi 1mg/g (1 Dosage Forms;)
The patient was hospitalized.This report could alert potential Movicolon Poeder Voor Drank In Sachet consumers.

Lower Respiratory Tract Infection, Angioedema, Agitation
In this report, a 75-year-old female patient from (weight: NA) was affected by a possible Movicol (nulytely /01053601/) side effect.The patient was diagnosed with NA. After a treatment with Movicol (nulytely /01053601/) (dosage: NA, start date: Sep 29, 2011), the patient experienced the following side effect(s):
  • Lower Respiratory Tract Infection
  • Angioedema
  • Agitation
The following simultaneously used drugs could have led to this reaction:
  • Amoxicillin (750 Mg (250 Mg, 3 In 1 D), Oral)
  • Irbesartan (150 Mg (150 Mg, 1 In 1 D), Oral)
  • Cosopt (cosopt)
  • Latanoprost
  • Chlorpheniramine Tab
  • Bendroflumethiazide (bendroflumethiazide)
  • Citalopram Hydrobromide
  • Risperidone (2 Mg (1 Mg, 2 In 1 D), Oral)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Movicol (nulytely /01053601/) treatment.

Epistaxis, Upper Gastrointestinal Haemorrhage
This is a report of a 64-year-old male patient from UNITED STATES (weight: NA), who used Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr (dosage: NA) for a treatment of NA. After starting a treatment on Nov 18, 2008, the patient experienced the following side effect(s):
  • Epistaxis
  • Upper Gastrointestinal Haemorrhage
The following drugs could possibly have interacted with the Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr treatment
  • Figitumumab (figitumumab) (10 Mg/kg, 1 In 3 Wk, Intravenous)
  • Diprobase Cream (cetostearyl Alcohol, Parafin, Liquid, Cetomacrogol, W
  • Docetaxel (165 Mg, 1 In 3 Wk, Intravenous)
  • Verapamil
  • Valsartan
  • Venlafaxin (venlafaxine Hydrochloride)
  • Innohep (16000 Iu (16000 Iu, 1 In 1 D), Subcutaneous)
  • Prednisolone (10 Mg (5 Mg, 2 In 1 D),)
The patient was hospitalized.Taken together, these observations suggest that a Movicol (sodium Bicarbonate, Potassium Chloride, Sodium Chloride, Macr treatment could be related to side effect(s), such as Epistaxis, Upper Gastrointestinal Haemorrhage.

Orthostatic Hypotension, Dizziness, Adrenal Insufficiency
This orthostatic hypotension side effect was reported by a health professional from UNITED KINGDOM. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Movicol (polyethyl. Glyc. W/ Potas. Chlor./sod. Bicarb.) (dosage: NA), which was started on Jan 19, 2011. Concurrently used drugs:
  • Aspirin
  • Carboplatin (330 Mg, Intravenous (not Otherwise Specified))
  • Gemcitabine (2000 Mg, Intravenous (not Otherwise Specified))
  • Prednisolone
  • Finasteride (finasteride) (finasteride)
  • Tamsulosin (tamsulosin) (tamsulosin)
When starting to take Movicol (polyethyl. Glyc. W/ Potas. Chlor./sod. Bicarb.) the consumer reported the following symptoms:
  • Orthostatic Hypotension
  • Dizziness
  • Adrenal Insufficiency
The patient was hospitalized. These side effects may potentially be related to Movicol (polyethyl. Glyc. W/ Potas. Chlor./sod. Bicarb.).

Arthralgia, Muscular Weakness, Bone Pain
This is a Movicol /01625101/ side effect report of a 35-year-old male patient (weight:NA) from IRELAND, suffering from the following symptoms/conditions: NA, who was treated with Movicol /01625101/ (dosage:NA, start time: May 09, 2011), combined with:
  • Dacarbazine
  • Dexamethasone
  • Emend /01627301/
  • Motilium /00498201/
  • Bleomycin Sulfate
  • Neupogen (30 Million Unit, Qd)
  • Doxorubicin Hcl
  • Vinblastine Sulfate
, and developed a serious reaction and a arthralgia side effect. The patient presented with:
  • Arthralgia
  • Muscular Weakness
  • Bone Pain
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Movicol /01625101/ treatment in male patients suffering from NA, resulting in arthralgia.

Agitation, Movement Disorder, Off Label Use, Headache, Dizziness, Condition Aggravated, Restless Legs Syndrome, Fatigue, Insomnia
This report suggests a potential Movicol /01749801/ agitation side effect(s) that can have serious consequences. A 84-year-old male patient from GERMANY (weight:NA) was diagnosed with the following health condition(s): NA and used Movicol /01749801/ (dosage: NA) starting NS. Soon after starting Movicol /01749801/ the patient began experiencing various side effects, including:
  • Agitation
  • Movement Disorder
  • Off Label Use
  • Headache
  • Dizziness
  • Condition Aggravated
  • Restless Legs Syndrome
  • Fatigue
  • Insomnia
Drugs used concurrently:
  • Ropinirole (See Image)
  • Palladon /00080902/
  • Magnesium
  • Neupro (See Image)
  • Molsidomin
  • Agiolax /00029101/
  • Pantozol /01263202/
  • Laxatives
The patient was hospitalized and became disabled. Although Movicol /01749801/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as agitation, may still occur.

Epilepsy
This epilepsy problem was reported by a physician from NETHERLANDS. A female patient (weight: NA) was diagnosed with the following medical condition(s): constipation,dry eye,multiple sclerosis relapse.On Mar 15, 2011 a consumer started treatment with Movicolon (dosage: NA). The following drugs/medications were being taken at the same time:
  • Duratears (Unk)
  • Methylprednisolone Acetate (Unk)
  • Fty 720 (0.5 Mg, Qd)
When commencing Movicolon, the patient experienced the following unwanted symptoms /side effects:
  • Epilepsy
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as epilepsy, may become evident only after a product is in use by the general population.

Blood Creatinine Increased, Febrile Neutropenia
This is a Movicolon side effect report of a male patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: NA and was treated with Movicolon (dosage: NA) starting Mar 28, 2011. Concurrently used drugs:
  • Pazopanib
  • Holoxan
  • Metoclopramide
  • Temazepam
Soon after that, the consumer experienced the following of symptoms:
  • Blood Creatinine Increased
  • Febrile Neutropenia
The patient was hospitalized. This opens a possibility that Movicolon could cause blood creatinine increased and that some male patients may be more susceptible.

Epilepsy
A female patient (weight: NA) from NETHERLANDS with the following symptoms: constipation,multiple sclerosis relapse,dry eye started Movicolon treatment (dosage: NA) on Mar 15, 2011. Soon after starting Movicolon treatment, the consumer experienced several side effects, including:
  • Epilepsy
. Concurrently used drugs:
  • Methylprednisolone Acetate (Unk)
  • Duratears (Unk)
  • Fty 720 (0.5 Mg, Qd)
This finding indicates that some patients can be more vulnerable to developing Movicolon side effects, such as epilepsy.

Subcutaneous Haematoma, Blood Pressure Decreased, Lower Respiratory Tract Infection, Injection Site Haemorrhage, Dysphagia, Somnolence, Urinary Tract Infection
This subcutaneous haematoma side effect was reported by a pharmacist from UNITED KINGDOM. A 87-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Movicol (macrogol, Potassium Chloride, Sodium Bicarbonate, Sodium Chlo (dosage: NA), which was started on Aug 07, 2010. Concurrently used drugs:
  • Trimethoprim (200 Mg, 2x/day)
  • Furosemide
  • Warfarin (warfarin) (3 Mg)
  • Warfarin (warfarin) (3 Mg)
  • Warfarin (warfarin) (3 Mg)
  • Omeprazole
  • Dihydrocodeine Compound
  • Zopiclone (zopiclone)
.When starting to take Movicol (macrogol, Potassium Chloride, Sodium Bicarbonate, Sodium Chlo the consumer reported symptoms, such as:
  • Subcutaneous Haematoma
  • Blood Pressure Decreased
  • Lower Respiratory Tract Infection
  • Injection Site Haemorrhage
  • Dysphagia
  • Somnolence
  • Urinary Tract Infection
These side effects may potentially be related to Movicol (macrogol, Potassium Chloride, Sodium Bicarbonate, Sodium Chlo. The patient was hospitalized.

Oropharyngeal Pain, Syncope
This is a report of a 12-year-old female patient (weight: NA) from AUSTRALIA, suffering from the following symptoms/conditions: intestinal obstruction, who was treated with Movicol (dosage: NA, start time: NS), combined with:
  • Ventolin
  • Flixotide (125mcg Twice Per Day)
  • Puffers
and developed a serious reaction and side effect(s). The consumer presented with:
  • Oropharyngeal Pain
  • Syncope
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Movicol treatment in female patients, resulting in oropharyngeal pain side effect.

Blood Pressure Decreased, Injection Site Haemorrhage, International Normalised Ratio Increased, Contusion
This report suggests a potential Movicol Blood Pressure Decreased, Injection Site Haemorrhage, International Normalised Ratio Increased, Contusion side effect(s) that can have serious consequences. A female patient (weight: NA) from UNITED KINGDOM was diagnosed with the following symptoms/conditions: NA and used Movicol (dosage: NA) starting NS. Soon after starting Movicol the patient began experiencing various side effects, including:
  • Blood Pressure Decreased
  • Injection Site Haemorrhage
  • International Normalised Ratio Increased
  • Contusion
Drugs used concurrently:
  • Trimethoprim
  • Zopiclone
  • Dalteparin Sodium
  • Warfarin Sodium
  • Ibuprofen
  • Dalteparin Sodium
  • Fentanyl
  • Levothyroxine Sodium
The patient was hospitalized. Although Movicol demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as blood pressure decreased, may still occur.

Aortic Arteriosclerosis, Aortic Stenosis, Cardiac Murmur, Inappropriate Antidiuretic Hormone Secretion, Abdominal Pain Upper, Blood Pressure Increased
This Aortic Arteriosclerosis, Aortic Stenosis, Cardiac Murmur, Inappropriate Antidiuretic Hormone Secretion, Abdominal Pain Upper, Blood Pressure Increased problem was reported by a health professional from NETHERLANDS. A 79-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Movicolon (dosage: NA). The following drugs were being taken at the same time:
  • Minirin (0.2 Milligram(s);daily;oral)
  • Thyroxin
  • Prev Meds
When commencing Movicolon, the patient experienced the following unwanted symptoms/side effects:
  • Aortic Arteriosclerosis
  • Aortic Stenosis
  • Cardiac Murmur
  • Inappropriate Antidiuretic Hormone Secretion
  • Abdominal Pain Upper
  • Blood Pressure Increased
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aortic arteriosclerosis, may become evident only after a product is in use by the general population.

Coma, Respiratory Depression
This is a report of a 89-year-old female patient (weight: NA) from SWITZERLAND. The patient developed the following symptoms/conditions: NA and was treated with Movicol (dosage: NA) starting Oct 01, 2010. Concurrently used drugs:
  • Dormicum
  • Amlodipine
  • Calcimagon D3
  • Trittico
  • Torem
  • Aprovel
  • Paspertin
  • Temgesic Sublingual
Soon after that, the consumer experienced the following side effects:
  • Coma
  • Respiratory Depression
The patient was hospitalized. This opens a possibility that Movicol treatment could cause the above reactions, including coma, and some female subjects may be more susceptible.

Syncope
A male patient (weight: NA) from NETHERLANDS with the following symptoms/conditions: prophylaxis,multiple myeloma started Movicolon treatment (dosage: NA) on Oct 27, 2010. Soon after starting Movicolon treatment, the subject experienced various side effects, including:
  • Syncope
Concurrently used drugs:
  • Thalidomide
  • Prednisone
  • Thalidomide
  • Melphalan
  • Ascal
  • Pantazol
  • Pcm
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Movicolon.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Movicol Side Effects

    Did You Have a Movicol Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Movicol for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective